You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Claims for Patent: 6,974,578

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,974,578

Title:	Method for treating secretions and glands using botulinum toxin
Abstract:	Method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of, Botulinum toxin types A, B, C, D, E, F and G.
Inventor(s):	Aoki; K. Roger (Laguna Hill, CA), Grayston; Michael W. (Irvine, CA), Carlson; Steven R. (Laguna Niguel, CA), Leon; Judith M. (Laguna Niguel, CA)
Assignee:	Allergan, Inc. (Irvine, CA)
Application Number:	08/627,118
Patent Claims:	1. A method of treating a secretion of a patient, the method comprising the step of administering to the patient an effective amount of Botulinum toxin in order to reduce the secretion, wherein the secretion is sweat. 2. The method of claim 1, wherein the secretion is a cholinergic influenced secretion. 3. The method of claim 1, wherein the botulinum toxin is botulinum toxin type A. 4. A method for treating a cholinergic influenced sweat secretion of a human patient, the method comprising the step of administering to a human patient a therapeutically effective amount of botulinum toxin type A in order to reduce the sweat secretion. 5. A method for treating a gland, the method comprising the step of administering to a gland a botulinum toxin thereby reducing a secretory activity of the gland, wherein the gland is a sweat gland. 6. The method of claim 5, wherein the gland is an excessively secreting sweat gland. 7. The method of claim 5, wherein the sweat gland is influenced by the cholinergic nervous system. 8. The method of claim 5, wherein the botulinum toxin is botulinum toxin type A. 9. The method of claim 5, wherein the botulinum toxin is administered by injection into the sweat gland or into the local area of the sweat gland. 10. A method for treating an excessively secreting sweat gland, the method comprising the step of injecting an excessively secreting, cholinergic nervous system influenced sweat gland or local sweat gland area of a human patient with a therapeutically effective amount of botulinum toxin type A in order to reduce the excessive sweat gland secretion. 11. The method of claim 1, wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G. 12. The method of claim 5, wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G.

Details for Patent 6,974,578

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Allergan, Inc.	BOTOX COSMETIC	onabotulinumtoxina	For Injection	103000	12/09/1991	⤷ Try a Trial	2013-12-28
Allergan, Inc.	BOTOX	onabotulinumtoxina	For Injection	103000	12/09/1991	⤷ Try a Trial	2013-12-28
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 6,974,578

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Australia	1516295	⤷ Try a Trial
Australia	688452	⤷ Try a Trial
Australia	7010598	⤷ Try a Trial
Australia	712502	⤷ Try a Trial
Canada	2180011	⤷ Try a Trial
Canada	2300386	⤷ Try a Trial
Canada	2300433	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.